Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SEAS: Ezetimibe + Simvastatin in Aortic Stenosis
NCT00092677Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Jan 2001
- Primary completion
- Apr 2008
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of ezetimibe and simvastatin in aortic stenosis (AS) (2 arms), sponsored by Organon & Co. Primary endpoint: Major Cardiovascular Events at 4.35 years. Started Jan 2001; status: completed.
02
Drugs
ezetimibesimvastatin
03
Conditions
aortic stenosis (AS)
Beyond the preview
Go deeper on NCT00092677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00092677.